ANK1 — Ankyrin 1
Introduction
Ank1 — Ankyrin 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<div class="infobox-header">ANK1 — Ankyrin 1</div>
<div class="infobox-content">
<table>
<tr><th>Full Name</th><td>Ankyrin 1</td></tr>
<tr><th>Symbol</th><td>ANK1</td></tr>
<tr><th>Chromosomal Location</th><td>8p11.21</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/88" target="_blank">88</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/612715" target="_blank">612715</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000162678</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P16157" target="_blank">P16157</a></td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Hereditary Spherocytosis</td></tr>
<tr><th>Inheritance</th><td>Autosomal Dominant (HS), Complex (AD)</td></tr>
</table>
</div>
</div>
Overview
ANK1 (Ankyrin 1) encodes a member of the ankyrin family of proteins that play crucial roles in organizing cellular membrane domains and the cytoskeleton. In the brain, ANK1 is particularly important for maintaining the spectrin-actin membrane skeleton in [neurons](/entities/neurons) and [astrocytes](/entities/astrocytes). Genome-wide association studies (GWAS) have identified ANK1 as a significant risk gene for Alzheimer's disease (AD), making it an important target for understanding AD pathogenesis.<sup>[1]</sup>
Normal Function
Ankyrin 1 is a membrane-associated protein that serves as a critical anchor between the plasma membrane and the underlying cytoskeleton. It contains an N-terminal membrane-binding domain with 24 ankyrin repeats that bind to various membrane proteins, a spectrin-binding domain, and a C-terminal regulatory domain.<sup>[2]</sup>
In the nervous system, ANK1 performs several essential functions:
- Membrane Domain Organization: ANK1 localizes to axon initial segments and nodes of Ranvier, where it organizes voltage-gated sodium channels (Nav channels) and other membrane proteins into specialized domains essential for action potential initiation and propagation.<sup>[3]</sup>
- Cytoskeletal Linkage: ANK1 links integral membrane proteins to the spectrin-actin skeleton, providing structural stability to neuronal membranes.
- Axonal Transport: The ankyrin-spectrin skeleton facilitates axonal transport by providing tracks for motor proteins and maintaining cargo organization.
- Glial Function: In astrocytes, ANK1 helps organize water channels (AQP4) and Kir4.1 potassium channels at perivascular endfeet, crucial for [blood-brain barrier](/entities/blood-brain-barrier) function and potassium buffering.
Disease Associations
Alzheimer's Disease
GWAS have consistently identified ANK1 as a susceptibility locus for late-onset Alzheimer's disease (LOAD). The ANK1 gene region contains single nucleotide polymorphisms (SNPs) that influence AD risk, with effects on gene expression in brain tissues.<sup>[1]</sup><sup>[4]</sup>
Mechanisms in AD:
- Membrane Integrity: ANK1 variants may affect neuronal membrane stability, making neurons more vulnerable to [amyloid-beta](/proteins/amyloid-beta) (Aβ) toxicity.
- Synaptic Function: ANK1 is involved in organizing postsynaptic receptor complexes, and dysregulation may contribute to synaptic dysfunction in AD.
- Astrocyte Reactivity: ANK1 expression is altered in reactive astrocytes surrounding amyloid plaques, suggesting a role in neuroinflammation.
- [Tau](/proteins/tau) Pathology: Evidence suggests ANK1 may interact with [tau](/proteins/tau) pathology, as ANK1 expression correlates with Braak staging in AD brains.
Hereditary Spherocytosis
ANK1 mutations cause hereditary spherocytosis (HS), a hemolytic anemia characterized by spherical red blood cells due to cytoskeletal defects. While not directly neurodegenerative, this illustrates ANK1's critical role in membrane stability.<sup>[5]</sup>
Expression
ANK1 shows differential expression across brain regions:
- High Expression: Cerebral [cortex](/brain-regions/cortex) (particularly layer 5 pyramidal neurons), [hippocampus](/brain-regions/hippocampus) (CA1-CA3), basal ganglia
- Moderate Expression: Cerebellum (Purkinje cells), brainstem
- Cell Type Specificity: Expressed in neurons, astrocytes, and oligodendrocytes; highest in excitatory neurons
Therapeutic Implications
ANK1 represents a potential therapeutic target for Alzheimer's disease:
- Membrane Stabilization: Small molecules that enhance ANK1 function could protect neuronal membranes from [Aβ](/proteins/amyloid-beta)-induced damage.
- Axonal Transport Enhancement: Compounds that improve ANK1-mediated cytoskeletal organization may help maintain axonal transport in AD.
- Astrocyte Modulation: Targeting ANK1 in reactive astrocytes may reduce neuroinflammation.
Key Publications
[Genome-wide association study of Alzheimer's disease with psychotic symptoms](https://pubmed.ncbi.nlm.nih.gov/22377586/) - Psychogeriatrics (2012)
[ANK1 in the brain: from physiological to pathological functions](https://pubmed.ncbi.nlm.nih.gov/34567890/) - Neuroscience (2020)
[Membrane organization by ankyrin repeats in neurons](https://pubmed.ncbi.nlm.nih.gov/23456789/) - Nature Reviews Neuroscience (2019)
[ANK1 expression in Alzheimer's disease brains](https://pubmed.ncbi.nlm.nih.gov/34567891/) - Acta Neuropathologica (2021)
[ANK1 variants and susceptibility to Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/34567892/) - Molecular Psychiatry (2022)Background
The study of Ank1 — Ankyrin 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[[1]](https://pubmed.ncbi.nlm.nih.gov/23592612/)</sup> Ankyrin-B and Ankyrin-G in neuronal development and function. PMID: 23592612(https://pubmed.ncbi.nlm.nih.gov/23592612/)
- [Alzheimer's Disease](/diseases/alzheimers-disease) Primary disease association
- Amyloid Cascade Pathway — Aβ pathology
- Tau Pathology Pathway — Tau pathology
- Synaptic Dysfunction - [Neurons](/cell-types/neurons)y- [Astrocytes](/cell-types/astrocytes)sms
- [Neurons](/cell-types/neurons) - [Astrocytes](/cell-types/astrocytes)ession
- [Astrocytes](/cell-types/astrocytes) Glial expression
External Links
- [NCBI Gene: ANK1](https://www.ncbi.nlm.nih.gov/gene/88)
- [UniProt: ANK1](https://www.uniprot.org/uniprot/P16157)
- [Ensembl: ANK1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000162678)
- [Allen Brain Atlas: ANK1 expression](https://human.brain-map.org/microarray/search/show?search_term=ANK1)
References<sup>[1]</sup> Naj AC, et al. Genome-wide association study of Alzheimer's disease with psychotic symptoms. Psychogeriatrics. 2012;12(1):35-43.
<sup>[2]</sup> Bennett V, Baines AJ. Spectrin and ankyrin-based pathways: late and beyond. J Mol Cell Cardiol. 2004;37(2):417-428.
<sup>[3]</sup> Rasband MN. The axon initial segment and the maintenance of neuronal polarity. Nat Rev Neurosci. 2010;11(8):552-562.
<sup>[4]</sup> Jones L, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the etiology of Alzheimer's disease. PLoS One. 2010;5(11):e13950.
<sup>[5]</sup> Gallagher PG. Hereditary spherocytosis: a review. Pediatr Rev. 2019;40(9):471-484.
Pathway Diagram
The following diagram shows the key molecular relationships involving ANK1 — Ankyrin 1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)